New name for Diabetes Insipidus (DI)

October 24, 2022

Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.

Diabetes Insipidus: a common condition for Histiocytosis and Pituitary conditions

August 16, 2022

Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.

Diabetes Insipidus Survey

March 16, 2015

This is a questionnaire/survey on Diabetes Insipidus. Thank you for participating.  Your responses and insights will be gleaned to write an article for Pituitary World News. Click here to start the Diabetes Insipidus Survey And stay tuned

dDAVP Therapy.  

October 20, 2014

From Lewis S Blevins Jr., MD – desamino d-arginine vasopressin… case you ever wondered. DDAVP therapy has evolved somewhat over the past quarter of a century. When I started my training one of the common